(Q37030853)

17 August 2017

1 reference

title

High hopes at high altitudes: pharmacotherapy for acute mountain sickness and high-altitude cerebral and pulmonary oedema (English)

1 reference

17 August 2017

0 references

0 references

1 reference

Ad Wright

1

1 reference

17 August 2017

Sp Brearey

series ordinal

2

1 reference

17 August 2017

Che Imray

series ordinal

3

1 reference

17 August 2017

language of work or name

English

0 references

publication date

1 January 2008

1 reference

Expert Opinion on Pharmacotherapy

17 August 2017

published in

1 reference

17 August 2017

volume

9

1 reference

17 August 2017

issue

1

1 reference

17 August 2017

page(s)

119-127

1 reference

Acute mountain sickness: medical problems associated with acute and subacute exposure to hypobaric hypoxia

17 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.1.119

High altitude cerebral edema.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.1.119

Acute mountain sickness: controversies and advances

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.1.119

No evidence of cerebral oedema in severe acute mountain sickness

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.1.119

Acute mountain sickness: influence of susceptibility, preexposure, and ascent rate

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.1.119

Normo or hypobaric hypoxic tests: propositions for the determination of the individual susceptibility to altitude illnesses

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.1.119

High-altitude cerebral edema evaluated with magnetic resonance imaging: clinical correlation and pathophysiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.1.119

High altitude cerebral and pulmonary edema

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.1.119

Role of O(2)-sensitive K(+) and Ca(2+) channels in the regulation of the pulmonary circulation: potential role of caveolae and implications for high altitude pulmonary edema

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.1.119

Pathogenesis of high-altitude pulmonary edema: inflammation is not an etiologic factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.1.119

High altitude-induced pulmonary oedema

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.1.119

Heterogeneous pulmonary blood flow in response to hypoxia: a risk factor for high altitude pulmonary edema?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.1.119

Magnetic Resonance Imaging of Uneven Pulmonary Perfusion in Hypoxia in Humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.1.119

The structure and function of carbonic anhydrase isozymes in the respiratory system of vertebrates

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.1.119

The Activity of Sulfonamides and Anions Against the Carbonic Anhydrases of Animals, Plants, and Bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.1.119

Carbonic anhydrase inhibitors and ventilation: a complex interplay of stimulation and suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.1.119

Mechanisms of action of acetazolamide in the prophylaxis and treatment of acute mountain sickness.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.1.119

Carbonic anhydrase inhibitors and hypoxic pulmonary vasoconstriction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.1.119

Efficacy and harm of pharmacological prevention of acute mountain sickness: quantitative systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.1.119

A dose-response study of acetazolamide for acute mountain sickness prophylaxis in vacationing tourists at 12,000 feet (3630 m).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.1.119

Effect of acetazolamide on pulmonary and muscle gas exchange during normoxic and hypoxic exercise.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.1.119

Inhibition of hypoxia-induced calcium responses in pulmonary arterial smooth muscle by acetazolamide is independent of carbonic anhydrase inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.1.119

Effects of acetazolamide on ventilatory, cerebrovascular, and pulmonary vascular responses to hypoxia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.1.119

Glucocorticoids as prophylaxis against acute mountain sickness

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.1.119

Nifedipine for high altitude pulmonary oedema

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.1.119

Effects of sildenafil on the human response to acute hypoxia and exercise.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.1.119

Effect of sildenafil and acclimatization on cerebral oxygenation at altitude.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.1.119

Theophylline and acetazolamide reduce sleep-disordered breathing at high altitude

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.1.119

Effect of magnesium, high altitude and acute mountain sickness on blood flow velocity in the middle cerebral artery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.1.119

Magnesium for the prevention and treatment of acute mountain sickness.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.1.119

Ginkgo biloba and acetazolamide prophylaxis for acute mountain sickness: a randomized, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.1.119

Randomised, double blind, placebo controlled comparison of ginkgo biloba and acetazolamide for prevention of acute mountain sickness among Himalayan trekkers: the prevention of high altitude illness trial (PHAIT).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.1.119

Acute mountain sickness; prophylactic benefits of antioxidant vitamin supplementation at high altitude

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.1.119

Temazepam at high altitude reduces periodic breathing without impairing next-day performance: a randomized cross-over double-blind study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.1.119

Acute hypoxia and cytochrome P450-mediated hepatic drug metabolism in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.1.119

Cytochrome P450 enzyme-mediated drug metabolism at exposure to acute hypoxia (corresponding to an altitude of 4,500 m).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.1.119

Sildenafil inhibits altitude-induced hypoxemia and pulmonary hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.1.119

Pathophysiological significance of peroxidative stress, neuronal damage, and membrane permeability in acute mountain sickness

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.1.119

Role of excitatory amino acids in hypoxic preconditioning

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.1.119

Change in plasma vascular endothelial growth factor during onset and recovery from acute mountain sickness

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.1.119

21 January 2018

High-altitude illness

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.1.119

Reliability and utility of a visual analog scale for the assessment of acute mountain sickness

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.1.119

Effects of high-altitude exposure on vascular endothelial growth factor levels in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.1.119

Greater free plasma VEGF and lower soluble VEGF receptor-1 in acute mountain sickness

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.1.119

21 January 2018

Identifiers

DOI

10.1517/14656566.9.1.119

1 reference

17 August 2017

1 reference